Ivermectin/ Permethrin for Scabies

• Status: Completed
• Trial end date: 2023-03-06
• Target enrollment: 0
• Participant gender: All

Summary

Scabies is a skin disease characterized by intense itching that worsens at night. It is very contagious, still has a high occurrence rate, and impacts patient quality of life. The use of scabicide followed by a clean and healthy lifestyle is the principle of scabies therapy. The primary treatment option for scabies is permethrin 5% cream. Ivermectin is an alternate treatment for scabies.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universitas Padjadjaran
• Treatments: Ivermectin; Permethrin

Criteria

Inclusion Criteria:

• Male or female

• Age 6 years or above

• Body weight 15kg or above

• Clinical establishment of diagnosed scabies

Exclusion Criteria:

• Pregnant or breastfeeding woman

• Scabies with secondary infection

• Scabies with eczematization

• History of receiving scabies treatment in the last four weeks

• History of drug hypersensitivity